And the hepatitis B vaccine is a purified vaccine, just containing the hepatitis B surface antigen. No other components. It’s an inactivated vaccine, no risk of acquiring hepatitis. It is produced in a yeast system so it does contain yeast protein, aluminum hydroxide as an adjuvant, as well as thimerosal. And if there’s time we’ll talk about the thimerosal issue which has resulted in some changes to the recommendations on the slides and in the syllabus, but these are very short term and for test-taking purposes we can just use the old schedule.
Cialis super active
The side effects of hepatitis B vaccine are mainly local side effects, local tenderness and these have an excellent vaccine response after immunization, greater than 95% immunogenicity in infants, greater than 90% efficacy and in general with this inactivated vaccine, giving the primary series of hepatitis B vaccine will result in at least an 8-10 year duration of immunity and this is still being followed up. But it looks very promising, in terms of long term immunity. In the future it may be required, but long duration immunity to date.
Generic viagra pharmacy
There are two different hepatitis B vaccines. In the past this has been very confusing in terms of different schedules, but for pediatrics – less than 20 years of age – there are two different vaccines but there is a unit dose for each of them, and so that really simplifies things. So the schedule for vaccination, for universal immunization, the routine recommendation is for infants of hepatitis B surface antigen-negative mother, to give a three -dose vaccine series – and there is a little bit of leeway in the recommendation – to give the first dose at two months, the second dose one to two months later, and the third dose at 6-18 months of age. Therefore you have these common schedules that you will see that fit within these guidelines; 0, 1 and 6 months, 2, 4 and 12 or 2, 4 and 6 months of age. The one caveat relates to preterm infants less than 2 kg do not have as good of an immune response to hepatitis B vaccine so the first dose should be given when they are 2 kg or two months of age. Now there has been the recent thimerosal issue which has occurred, with new recommendations in July of this year, to delay the first dose of hepatitis B vaccine to at least two months of age because it does contain thimerosal. That is a temporary issue. The manufacturers of hepatitis B vaccine should have thimerosal-free hepatitis B vaccine available within the next few months. If there is a cutting edge issue, it is interesting how these recommendations came about, but for taking the Pediatric Board, I would just follow these old recommendations.
Human Growth Hormone online
Now for infants of hepatitis B surface antigen-positive mothers, they need also to get hepatitis B immune globulin, H-BIG, within 12 hours of birth and this provides immediate antibody. In addition, hepatitis B vaccine should be given at 0, 1 and 6 months of age. The first dose within 12 hours of birth and this will result in sustained antibody production. The hepatitis B Vaccine and H-BIG may be administered simultaneously but they should be at separate sites and obviously with separate syringes. There is no changes regarding the thimerosal issue in regards to infants of hepatitis B surface antigen-positive mothers. Also no changes in instances of mothers who have unknown hepatitis B surface antigen status. These children should get hepatitis B vaccine at 0, 1 and 6 months of age. The mother should be screened. If they are hepatitis B surface antigen-negative, then they can just complete the series. If they are hepatitis B surface antigen-positive then they should receive hepatitis B immune globulin as soon as possible, and complete the vaccine series as well.
With the different vaccines there are different schedules. In general, you give a primary series of either two or three doses of H. flu type B vaccine and then you give a booster dose at 12-15 months. Now the thing that makes this a little more complicated is that one of these vaccines, the Merck product, you only give two doses for the primary series and you don’t need to give the third dose at six months of age. So these vaccines are interchangeable, however if you do interchange these vaccines you should err on the side of getting more vaccine doses rather than less. For example, if you give the first dose of PedvaxHIB at two months of age and then you switch over to HibTITER for the second dose, then you need to also give the third dose of HibTITER and then another dose at 12-15 months of age. Otherwise these vaccines are interchangeable.
Canadian kamagra
In terms of catch-up immunization with HIB vaccines, it’s important to know that the older one is, the less doses one needs of HIB vaccine. So that after 15 months of age you only need to give one dose at time zero and you don’t need to give a whole primary series, just the one dose.
Then you need to be aware of combination vaccines. HIB may occur not just alone as a single antigen, but may occur in combination with whole cell DTP vaccine, and this may result in a decreased number of immunizations at 2,4,6 and 12-18 months of age. However, remember, DTP vaccine, whole cell DTP vaccine, is not routinely recommended anymore. What’s preferred is the acellular pertussis component vaccine.
Abilify online at licensed online pharmacy.
Well, let’s move on and talk about the DTaP-HIB combination vaccine. Great idea, and unfortunately this is only approved for use at the fourth dose of a vaccine series only; 12-18 months of age. Do not give this vaccine at 2, 4 and 6 months of age. Do not give the combination vaccine. That’s wrong, it’s contraindicated, it’s not approved for use. There is a decreased immune response to the vaccine components when it is given at 2, 4, 6 months of age. And then there is the HIB and hepatitis B vaccine combination, and this can be useful to decrease the number of injections at 2 months, 4 months and 12 months of age. But in terms of knowing all the different vaccines and combinations that exist, it’s important to know that you do have choices and it’s important to know when these choices may be possible and when they shouldn’t be given.
Now I am going to move on and talk about hepatitis B vaccine and the strategy behind recommending universal immunization against hepatitis B. The rationale behind that is that hepatitis B does occur in this country. What we are most familiar with, though, is acute hepatitis B infection. Symptomatic infection which may result in death due to fulminant hepatitis; about 400 per year as shown on this slide from the CDC. Now what may also occur is asymptomatic infection with hepatitis B and whether it’s asymptomatic or symptomatic, chronic carrier carriage may occur following infection with hepatitis B. And this is where the main problem exists in terms of public health importance. Is that chronic carriers can get chronic disease, either death due to cirrhosis or death due to liver cancer, and if you add these up you can see that the chronic disease, death due to chronic liver disease, due to chronic carriers is ten times more important as a public health issue compared to death from acute symptomatic hepatitis B. That’s why it’s important to prevent chronic carriage. Where that enters into pediatrics is shown on this graph by the CDC, which is the inverse correlation between age and risk of having chronic carriage; that is, the younger the age, those who acquire hepatitis B at birth have a 90% risk of becoming chronic carriers and those who get hepatitis B at a year of age, 50% risk, and older children and adults only 5-10% risk of becoming a chronic carrier. Viagra Jelly online without prescription. So really, preventing hepatitis B at the youngest age can really have a major impact on preventing chronic carriage of hepatitis B and that’s where the main number of deaths occur. A lot of times it is said that, “Well, the kids that I’m treating, my population, aren’t at risk. They don’t have the classic risk factors for hepatitis B” and this slide from the CDC shows intensely investigated cases of acute hepatitis B. The usual risk factors that we are familiar with; IV drug use, high risk heterosexual or homosexual activity or needle stick. But you can see that 35-40% of cases of acute hepatitis B don’t have these classic risk factors and so everybody is at risk for hepatitis B whether they have the classic risk factor or not. Children especially are at risk of becoming chronic carriers. So because of this we do recommend universal immunization with hepatitis B vaccine.
Finally, the last part of MMR vaccine; the R is for rubella vaccine and rubella vaccine is also a live virus vaccine. The strategy to prevent intrauterine infection in this country, to prevent congenital rubella syndrome, is to vaccinate everybody routinely. To do that you give the rubella vaccine, the live virus vaccine. The main reactions to be concerned about are an attenuated form of rubella. A mild rash, a low-grade fever, and in children sometimes you get some occipital or posterior auricular lymphadenopathy and arthralgia. In young women the rubella vaccine may be slightly more reactagenic, resulting in not only transient arthralgias but sometimes transient arthritis as well.
Female viagra
Precautions and contraindications are similar; pregnancy, immunocompromised – it might multiply more than you would want it to in that situation – and immune globulin will interfere with vaccine take. Excellent seroconversion is obtained with rubella vaccine. Again, a graph from the CDC shows a marked reduction in the cases of rubella in this country. It’s been quite successful.
Cefaclor online without prescription.
So now we are going to move on from MMR vaccine and move on to H. flu type B vaccine. I haven’t talked much about the science behind a lot of these vaccines and that’s because that’s not important for test-taking purposes. However, with H. flu type B vaccine, that’s different. So I am going to spend a little bit talking about the science behind it. The important thing with H. flu type B in terms of immunity is immunity to the polysaccharides. However if you take the plain polysaccharide and you use that as a vaccine, it’s very weak. You get a very weak antibody response in infants and really don’t get a very good antibody response until 18-24 months of age. If you take this polysaccharide and you bind it to a protein, then it becomes a T-cell dependent immunogen. Canadian viagra for sale. It has enhanced immunogenicity, especially in infants, you get a better immune response and you get a booster response if you give repeated doses of vaccine or if you get exposure to H. flu type B. Because of this has been remarkably successful, as you’ll see. This is being applied to other vaccines and development of other vaccines, such as improved vaccine against pneumococcus, improved vaccine against meningococcus. And because of that, because you will see it in the future, this is the kind of thing, that basic science sort of thing, that actually may be tested because I think it is important to understand that this technology is improving vaccines.
Men with erectile dysfunction issues find viagra soft tablets a reliable solution.
So there are several different vaccines in general. It’s not important to know the main differences between them, but there are different manufacturers of the vaccine. The polysaccharide is linked to different protein carriers. Most of these have been used before so there is a lot of clinical experience with them, and that’s why they have been chosen. But all of them are very safe vaccines, very minor reactions, local reactions. Rarely you get a low-grade fever after vaccination with the routinely used HIB vaccines. Again, these have been remarkably successful. The conjugate vaccines were introduced in 1988 and then in 1990 they were recommended for infants. You can see invasive H. flu type B disease in this country more than a 95% reduction. This has been quite a success story.
Recent Comments